Brief: Cipher Pharmaceuticals Announces Plecanatide Accepted For Review By Health Canada
17/12/2018 12:09
Dec 17 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO :
* CIPHER PHARMACEUTICALS ANNOUNCES PLECANATIDE ACCEPTED FOR
REVIEW
BY HEALTH CANADA
* CIPHER PHARMACEUTICALS INC - CONTINUE TO EXECUTE ON GROWTH
STRATEGY AND LAUNCHING PLECANATIDE IN LATE 2019
Source text for Eikon: ID:nCNWpfyzya
Further company coverage: CPH.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million